What are the prospects for Fmoc-PEG

Diabetes is a dangerous chronic disease that not only causes polyuria and weight loss but in severe cases may also lead to complications such as atherosclerosis, hypertension, glomerulosclerosis, retinopathy, and blindness. To avoid the appearance of these hazards, it is important to take diabetes seriously and not to be afraid if you have it. As long as we control our diet reasonably and adhere to our medication is to slow down the progress of the disease. There is a wide range of glucose-lowering drugs on the market, and the advantages of those containing Fmoc-PEG are very obvious. So do you know what the prospect of Fmoc-PEG is?

Here is the content list:

•Medical prospects

•Market prospects

Medical prospects

The use of Fmoc-PEG currently enhances the pharmacokinetic and pharmacodynamic properties of previous small molecule drugs. the improved pharmacokinetics of first-generation polyethylene glycol-drug couples were not very satisfactory due to the non-biodegradable nature of the first-generation small molecule drug couples and limitations on molecular mass. Fmoc-PEG exhibits improved pharmacokinetics and pharmacodynamics. The future of poly(ethylene glycol)-based Fmoc-PEGs is geared towards third-generation poly(ethylene glycol) chemistry with the aim of achieving maximum efficacy and extended drug molecule half-life, site-specificity, and low dose. This could be achieved by electrostatically linked non-covalent PEG modifications. If successfully achieved, with the help of further studies, Fmoc-PEG could have great potential in the treatment of diabetes.

Market prospects

In recent years, the global prevalence of diabetes has been increasing year on year with the accelerated aging process, the urbanization of economic development, and the growing obesity epidemic. In 2017, the number of people with diabetes will reach 424.9 million, and the International Diabetes Federation predicts that it will reach 628.6 million by 2045. The development and popularity of glucose-lowering drugs will become increasingly important, and the future market for Fmoc-PEG, an important ingredient in some glucose-lowering drugs, is immeasurable. Diabetes is a chronic disease with a low mortality rate. Under current medical conditions, the majority of patients with diabetes are irreversible, and failure to treat the disease will lead to serious complications, requiring patients to take medication for life. These attributes make the market for diabetes treatment drugs vast and have led to the emergence of new and old drugs to meet the needs of diabetes patients. Fmoc-PEG stands out among the many medical intermediates for glucose-lowering drugs and will certainly be used more widely in the future.

Diabetes mellitus is a chronic, comprehensive disease caused by absolute or relative insulin deficiency or reduced insulin sensitivity in target cells, with type 2 diabetes mellitus occurring as a result of a combination of peripheral insulin resistance and beta-cell dysfunction. Fmoc-PEG is one of the medical intermediates of glucose-lowering drugs and plays an important role in the treatment of diabetes. If you need Fmoc-PEG, you can consider our cost-effective products. Chengdu Pukang Biotechnology Co., Ltd are non-toxic and tasteless, perfect after-sales service, you can have no worries. Chengdu Pukang Biotechnology Co., Ltd was founded in 2008 and it is located in the national cross-strait science and technology industry development park——Cross-Strait Science and Technology Park, Wenjiang District, Chengdu，specializing in the long-term development of peptide drugs for chronic disease.